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Abstract
The inflammasome has been recently implicated in obesity-associated dys-metabolism. However, of its products, the
specific role of IL-1b was clinically demonstrated to mediate only the pancreatic beta-cell demise, and in mice mainly the
intra-hepatic manifestations of obesity. Yet, it remains largely unknown if IL-1b, a cytokine believed to mainly function
locally, could regulate dysfunctional inter-organ crosstalk in obesity. Here we show that High-fat-fed (HFF) mice exhibited a
preferential increase of IL-1b in portal compared to systemic blood. Moreover, portally-drained mesenteric fat
transplantation from IL-1bKO donors resulted in lower pyruvate-glucose flux compared to mice receiving wild-type (WT)
transplant. These results raised a putative endocrine function for visceral fat-derived IL-1b in regulating hepatic
gluconeogenic flux. IL-1bKO mice on HFF exhibited only a minor or no increase in adipose expression of pro-inflammatory
genes (including macrophage M1 markers), Mac2-positive crown-like structures and CD11b-F4/80-double-positive
macrophages, all of which were markedly increased in WT-HFF mice. Further consistent with autocrine/paracrine functions
of IL-1b within adipose tissue, adipose tissue macrophage lipid content was increased in WT-HFF mice, but significantly less
in IL-1bKO mice. Ex-vivo, adipose explants co-cultured with primary hepatocytes from WT or IL-1-receptor (IL-1RI)-KO mice
suggested only a minor direct effect of adipose-derived IL-1b on hepatocyte insulin resistance. Importantly, although IL-
1bKOs gained weight similarly to WT-HFF, they had larger fat depots with similar degree of adipocyte hypertrophy.
Furthermore, adipogenesis genes and markers (pparg, cepba, fabp4, glut4) that were decreased by HFF in WT, were
paradoxically elevated in IL-1bKO-HFF mice. These local alterations in adipose tissue inflammation and expansion correlated
with a lower liver size, less hepatic steatosis, and preserved insulin sensitivity. Collectively, we demonstrate that by
promoting adipose inflammation and limiting fat tissue expandability, IL-1b supports ectopic fat accumulation in
hepatocytes and adipose-tissue macrophages, contributing to impaired fat-liver crosstalk in nutritional obesity.
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Introduction
The inflammasome plays an increasingly recognized role in the
pathogenesis of human diseases, including obesity and Type2
diabetes [1,2]. Two fundamental questions remain outstanding: i.
What is the specific role of various inflammasome products in
obesity? Now, that cytokines other than IL-1b (e.g., IL-18, IL-33)
are known to be generated by activated inflammasome, what
would constitute the specific effects of IL-1b, the only cytokine of
this family that can currently be clinically targeted; ii. How can
systemic and/or inter-organ communication phenomena be
mediated by factors mostly recognized to act locally? Can they
also function directly, as endocrine mediators?
Related to obesity and type 2 diabetes, circulating levels of IL-
1b were demonstrated to predict Type 2 diabetes when in
conjunction with circulating IL6, suggesting a potential role for
circulating IL-1b levels (though not as sole factor) [3]. At the local
tissues sites, bariatric surgery-induced weight-loss was shown to
diminish IL-1b expression in both subcutaneous fat and in the
liver [1]. However, the most direct clinical evidence yet for IL-1b’s
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role in the pathogenesis of type 2 diabetes has been obtained by
antagonizing or neutralizing IL-1b: Treatment of Type2 diabetes
patients with Anakinra (IL-1 receptor antagonist, IL-1Ra) linked
this ubiquitous inflammatory cytokine mainly to the pancreatic
beta-cell demise that is required for diabetes to manifest [4]. Using
mouse diet-induced obesity models, targeting various components
of the inflammasome, including NLRP3 [5,6], caspase-1 [7] and
ASC [7] was shown to either prevent obesity, and/or to relieve
obesity-induced manifestations [5], in particular whole-body
insulin resistance and hepatic steatosis [7,8]. Yet, specifically
addressing the involvement of IL-1b was more directly studied
using IL-1-receptor (IL-1R) knockout mice [9]. This study
demonstrated improved insulin sensitivity and prevention of IL-
1-TNFa synergism in inducing adipocyte insulin resistance.
Complementarily, IL-1b knockout mice were more insulin
sensitive on either normal chow or high fat diet [6,10], and both
IL-1b and IL-1a knockouts were protected against hepatic
steatosis induced by high fat or atherogenic diets [7,11]. But do
these represent merely effects of locally-produced IL-1b, or could
arise directly or indirectly from the effect of this cytokine in other
sites, thereby regulating inter-organ crosstalk?
Adipose tissue inflammation is now a well-recognized manifes-
tation of obesity [12]. One of its major consequences is thought to
be hepatic insulin resistance and steatosis, tied to adipose
inflammation particularly when involving visceral fat that is
drained via the portal vein, a notion known as the "portal theory"
[13,14]. This dysfunctional fat-liver crosstalk is currently best
supported by several mouse models in which inflammatory
mediators (Fas/CD95) and/or inflammatory signals (JNK1) were
disrupted specifically in adipocytes, resulting in protection against
diet-induced hepatic steatosis and insulin resistance [15,16]. More
directly, adipose tissue transplantations allowed to increase the
mass of low-grade inflamed adipose tissue (secondary to the
surgical procedure) independently of other effects of obesity [17].
Remarkably, only mesenteric transplantation drained via the
portal vein to the liver, but not systemically-drained transplant,
induced hepatic insulin resistance [17,18]. In both human and
rodent obesity adipose tissue expression of IL-1b is up-regulated,
more in visceral than subcutaneous fat [1,19], but its contribution
to adipose inflammation is not clear: whereas NLRP3-KO mice
do show diminished adipose macrophage infiltration [5], this was
not significantly observed with IL-1RIKO [9], though macro-
phage inflammatory phenotype (IL-6 and TNFa secretion) was
nevertheless diminished. Ex-vivo/in-vitro systems demonstrated
diverse roles of IL-1b on adipocyte function, including activation
of lipolysis [20], insulin resistance [21] and inhibited adipogenesis
[22,23], though the latter wasn’t consistently reported [24].
Exploring the potential crosstalk with the liver, we recently
demonstrated up-regulation of adipocyte expression and secretion
of IL-1b in response to inflammatory stimulus [25]. Moreover, we
proposed that IL-1b may constitute a mediator in the dysfunc-
tional communication between adipocytes and hepatocytes,
resulting in insulin resistance of the latter cell type [25].
In the present study we utilized a series of ex-vivo and in-vivo
approaches that combine tissues from wild-type and knockout
models to better define the role of IL-1b in inter-organ
communication. IL-1b was found to promote adipose tissue
inflammation, limit fat tissue expandability, contribute to ectopic
fat accumulation and to disturbed fat-liver crosstalk.
Results
Consistent with previous studies [5,10], wild-type (WT) mice
exhibited a time-dependent increase in adipose tissue expression of
IL-1b (IL-1b), IL-1 converting enzyme 1 (caspase-1, casp1), but not
IL-1a, when on high fat diet (HFF) (Fig. S1). To begin assessing a
potential role for fat tissue-derived IL-1b as a direct-endocrine
mediator in adipose-liver crosstalk, we measured the level of this
cytokine in systemic versus portal blood. Although measured IL-1b
levels were low, they were in most mice above the detection limit
of the ELISA kit. HFF induced a preferential increase in IL-1b in
portal blood compared to its levels in the systemic circulation in
the majority of mice (Fig. 1A). To generate an in-vivo setting for
testing the isolated effect of increased portal delivery of IL-1b, we
utilized mesenteric (portally-drained) adipose tissue transplantation
from WT or IL-1b-knockout (KO) mice, as recently described
(Fig. 1B) [17]. Transplanted WT mice indeed had elevated portal
vein levels of IL-1b (Fig. 1C), consistent with the procedure-
associated low-grade inflammation of the transplant [17]. To
specifically address the role of the fat-transplant-related IL-1b on
liver function, we assessed the pyruvate-glucose flux in mice
receiving transplant from either WT or IL-1bKO mice.
Compared to sham-operated controls, mice receiving a transplant
from WT, but not IL-1bKO mouse, had a higher rise in blood
glucose levels during pyruvate tolerance test (PTT, Fig. 1D, E).
This finding suggests that the absence of IL-1b in the transplant
prevented the augmented conversion of pyruvate to glucose
induced by increased mass of portally-drained adipose tissue.
To determine if adipose-derived IL-1b can directly regulate fat-
liver communication or rather act locally to alter adipose tissue
adaptation in obesity, we utilized co-culture of primary hepato-
cytes with adipose tissue explants (Fig. 2A). Adipose tissue explants
from WT-NC mice somewhat attenuated insulin-stimulated Akt
though not GSK3 phosphorylation in primary hepatocytes from
IL-1RI (i.e., isolated from IL-1R1KO mice, Fig. 2B, C). In
addition, a significant, near-complete diminution of hepatocyte
insulin responsiveness was induced by adipose explants from WT-
HFF mice, suggesting an effect independent of hepatocyte IL-1RI
(Fig. 2B, C). Furthermore, primary hepatocytes from WT mice co-
cultured with adipose tissue explants from IL-1bKO-HFF mice
responded better to insulin stimulation than the same cells
incubated with fat explants from WT-HFF mice. However,
blocking the direct effect of IL-1b with IL-1 receptor antagonist
(IL-1Ra) only partly and with marginal statistical significance
corrected insulin responsiveness of WT hepatocytes co-cultured
with WT-HFF explants. Collectively these results demonstrate that
diet-induced obesity in the absence of IL-1b alters adipose tissue in
a manner less detrimental to adipose-liver crosstalk. Yet, in WT
conditions when IL-1b is present, it does not seem to directly
mediate the disturbed fat-liver crosstalk induced by obesity.
Rather, adipose-derived IL-1b seems to act primarily locally to
regulate adipose tissue adaptation to obesity, consequently
resulting in impaired fat-liver crosstalk.
To begin addressing the local role of IL-1b in adipose
adaptation to diet-induced obesity, we tested the effect of HFF
on adipose tissue expression of pro-inflammatory cytokines in IL-
1bKO mice (Fig. 3A). As expected, IL-1b mRNA levels were non-
detectable in IL-1bKO mice on either diet. Importantly, in the
absence of IL-1b, HFF induced only a 1.1-and 1.8–fold increase in
il6 and tnfa mRNA, much less than in WT mice. Histological
sections of adipose tissue stained with haematoxylin-eosin (H&E)
or immunostained with anti-Mac2 revealed that HFF induced a
significant infiltration of macrophages in crown-like structures
(CLS, inflammatory cells surrounding adipocytes), whereas this
was less evident in IL-1bKO mice (Fig. 3B, C, E, F).
Complementarily, f4/80 mRNA, a marker of macrophage
infiltration into the tissue measured by quantitative real-time
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PCR, revealed only a 7.4-fold induction by HFF in the IL-1bKO,
much less than in- WT mice (31.7-fold) (Fig. 3D,G).
We further characterized how the lack of IL-1b altered the non-
adipocyte cellular component of adipose tissue in response to HFF
using FACS analyses. Following isolation of the SVF and exclusion
of dead (propidium iodide–positive) cells, SVC were gated for
CD45 to detect leukocytes, and in this fraction macrophages were
identified based on double-positive staining of F4/80 and CD11b
(Fig. 4A). Consistent with other reports [26], obesity greatly
increased the number of CD45-positive cells and adipose tissue
macrophages (ATMs, Fig. 4B, C, respectively). However, IL-
1bKO-HFF mice exhibited only a non-significant increase in total
number of leukocytes, and only a small increase in the number of
ATMs. ATMs may accumulate triglycerides by engulfing lipid
droplet remains of dead adipocytes [19], and/or by re-esterifying
free fatty acids released from adipocytes [27]. We therefore used
the fluorescent neutral lipid stain Bodipy to assess ATM lipid
content (Fig. 4D). In WT mice HFF increased 12.1-fold the mean
lipid fluorescence in ATMs compared to WT-NC. IL-1bKO-HFF
however exhibited a significant attenuation of HFF-induced
increase in the mean ATMs’ lipid content (Fig. 4E). Complemen-
tarily, cultured J774.1 mouse macrophage cells incubated in-vitro
Figure 1. Role of adipose IL-1b in adipose-liver cross-talk as revealed by portally-drained mesenteric adipose tissue
transplantation. (A) Serum IL-1b levels were measured in peripheral (systemic) or portal vein blood in WT mice fed normal chow (WT-NC) or
high fat diet (WT-HFF). Connecting lines indicate the paired systemic-portal samples from a single mouse, n = 17–19. Red symbols represent$20%
higher IL-1b level in the portal compared to the systemic blood; (B) Schematic representation of the mesenteric adipose tissue transplantation
experimental flow. (C)Portal blood levels of IL-1b were measured in sham-operated (n = 9) and in mice receiving mesenteric adipose tissue
transplantation from a littermate WT mouse (Trans-WT, n = 13)*p,0.05. (D, E) Intra-peritoneal pyruvate tolerance test (PTT, 2 gr/Kg body weight) was
performed in Sham (n = 9), Trans-WT (n = 13), and in mice receiving transplants from IL-1bKO mice (Trans-IL-1bKO, n = 7) four weeks post-
transplantation. Area under the glucose levels curve (AUC) was calculated; *p,0.05 compared to Sham-operated controls.
doi:10.1371/journal.pone.0053626.g001
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with free fatty acids or aggregated LDL revealed that adding IL-1b
to the culture medium enhanced lipid accumulation (Fig. S2A, B),
consistent with a previous report demonstrating such effect with
both IL-1b and TNFa [28].
The findings above offered a putative effect of locally-produced
IL-1b along with adipose tissue microenvironment on ATMs.
Further along this line, we assessed how in the absence of IL-1b
HFF altered the inflammatory profile of adipose tissue and ATMs
by measuring the mRNA levels of several M1/M2 genes
("classically-activated"/"alternatively-activated" macrophages)
(Fig. 4F,G) [29]. Consistent with other reports in mice [30] and
in humans [31], obese mice showed a significant increase in M1
and in some of the M2 genes. In IL-1bKO mice this obesity
induced change in the M1 and M2 genes was markedly less
pronounced. Collectively, the adipose tissue response to HFF in
IL-1bKO mice uncovers a major role for IL-1b in the
development of adipose tissue inflammation in response to diet-
induced obesity.
Adipocyte hypertrophy and associated cell death may be major
drivers of adipose tissue inflammation in obesity. Conversely,
cellular hyperplasia may support increased adipose tissue expand-
ability that prevents "ectopic" triglyceride storage in non-adipose
tissues like the liver. We therefore tested if the attenuated HFF-
induced adipose tissue inflammation in IL-1bKO-HFF mice was
associated with altered adipose tissue expandability. Body com-
position analysis using computed tomography (CT) revealed that
Figure 2. Role of adipose IL-1b in hepatocyte insulin resistance as revealed by co-culture approach. (A) Schematic representation of the
fat explants – primary hepatocyte co-culture experimental design. (B) Insulin-stimulated Akt and GSK3 phosphorylation in primary hepatocytes from
IL-1RIKO liver co-cultured or not with fat explants from WT-NC or WT-HFF and densitometry analysis of 2–5 mice per group. *p = 0.05 compared to
incubation with fat explants from WT-HFF mice. (C) Insulin-stimulated Akt phosphorylation in primary hepatocytes from WT mice co-cultured with fat
explants from WT-HFF, IL-1bKO-HFF, or WT-HFF in the presence of IL-1 receptor antagonist (WT-HFF+RA). The right graph depicts densitometry
analysis of 7–9 mice per group. *p,0.05 compared to the signal obtained from primary hepatocytes incubated with fat explants from WT-HFF mice.
doi:10.1371/journal.pone.0053626.g002
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HFF caused expansion of adipose tissue compartments in WT
mice. After 16w on HFF, both epididymal fat and liver weights
were significantly increased compared to WT-NC (Fig. 5A).
Remarkably, although IL-1bKO gained similar total body weight
compared to WT mice when on HFF (Fig. S4), adipose tissues
accumulation appeared to exceed that which was observed in WT-
HFF mice in both the intra-abdominal cavity and in subcutaneous
depots (Fig. 5B). Yet, no similar increase in liver size was observed,
in contrast to WT mice (Fig. 5A, B). This corresponded
histologically to the extent of lipid accumulation, with
Figure 3. High fat feeding induces only a minor adipose tissue macrophage infiltration in IL-1bKO mice. (A) Quantitative real-time PCR
analysis of adipose tissue (epididymal fat pad) of IL-1b, il6 and tnf (normalized to tbp, 18S and 36b4). n$3 per group. (B–D) Representative X20 light
microscopy images of adipose tissue stained with H&E or with anti-Mac2 antibody. The mean6SEM number of crown like structures (CLS) per X10
microscopic field was counted as described in Materials and Methods. mRNA levels of f4/80, a macrophage marker, was assessed by quantitative real-
time PCR. (E–G) Similar analysis as described above (B–D), but for IL-1bKO-NC and IL-1bKO-HFF mice. n = 3–6 animals per group were included in the
analysis. *p,0.05 compared to IL-1bKO-NC; ***p,0.001 compared to WT-NC.
doi:10.1371/journal.pone.0053626.g003
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56.166.9% versus 27.565.5% of the sections area being steatotic
in WT-HFF versus IL-1bKO-HFF, respectively (Fig. S3). Inter-
estingly, in HFF mice a higher fat mass correlated with lower liver
weight (Fig. 5C), supporting the proposition that in the absence of
IL-1b greater expansion of adipose tissue protected against ectopic
fat accumulation in the liver.
To gain further insight on the mechanisms for increased adipose
tissue expandability in IL-1bKO-HFF mice we assessed adipocyte
Figure 4. Role of IL-1b in adipose tissue macrophage recruitment, ATM lipid content, and adipose inflammatory profile in dietary
obesity. (A) FACS plots and gating of the stromal-vascular cells (SVCs) to detect adipose tissue macrophages (ATMs). Leucocytes (B), ATMs (C) in
adipose tissue of WT-NC (n = 4), WT-HFF (n = 11), IL-1bKO-NC (n = 3) and IL-1bKO-HFF (n = 7). (D) Histogram of lipid content (determined with Bodipy)
in representative mice of the 4 mouse groups (E). Quantitative real-time PCR analysis of M1 or M2- genes in epididymal adipose tissue of (F) WT-NC,
WT-HFF (n = 4, 11, respectively), and (G) IL-1bKO-NC and IL-1bKO-HFF (n = 3 and 7, respectively). The expression of each transcript was normalized to
tbp, 18S and 36b4 mRNA/rRNA, and a value of 1 was assigned to the normal chow group (NC) of each strain. *p,0.05, compared to NC; **p,0.01
compared to NC ***p,0.001.
doi:10.1371/journal.pone.0053626.g004
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size distribution. Using a semi-automated quantitative analysis of
histological sections revealed that overall HFF induced a similar
shift towards larger adipocytes in IL-1bKO and WT mice
(Fig. 5D). This suggests that the increased adipose tissue mass of
IL-1bKO-HFF compared to WT-HFF could not be attributed to
greater diet-induced adipocyte hypertrophy, and therefore largely
relied on an increase in adipocyte cell number. Consistently,
whereas in WT mice HFF induced a decrease in early (pparg, cebpa)
and late (fabp4, glut4) adipogenic markers, as previously reported
[32,33], IL-1bKO mice showed significant increase in pparg, cebpa
and fapb4 and no change in glut4 (Fig. 5E). This unique increase in
adipogenic genes in response to HFF could support augmented
adipose tissue expansion in the absence of IL-1b.
Discussion
The fundamental role of IL-1b in inflammatory cascades is well
established, as is now the recognition of adipose tissue inflamma-
tion in obesity-associated-morbidities. Yet, whether and how IL-
1b regulates adipose inflammation and fat-liver crosstalk in obesity
is poorly defined. The present study reveals that: i. IL-1b regulates
lipid storage capacity in adipose tissue, in ATMs, and as previously
shown, in the liver [11]. In its absence, adipose tissue expand-
ability increases in response to excess calories, correlating with
lower liver weight and less (ectopic) lipid storage. ii. IL-1b is a
major promoter of adipose tissue inflammation in obesity. iii. IL-
1b regulates adipose-liver crosstalk, mainly having local effects in
both tissues. IL-1b-mediated autocrine/paracrine actions in
adipose tissue that promote local inflammation and limit
expandability generate a dysfunctional fat-liver communication
that could contribute to liver steatosis and insulin resistance.
Regulation of TG Storage in Obesity
Previous studies have demonstrated local effects of IL-1b on
either adipocytes or hepatocytes, both of which can contribute to
hepatic lipid accumulation in obesity: In cultured adipocytes IL-1b
was shown to induce lipolysis by down-regulating PPARc [20].
Such an effect in an in-vivo setting would result in increased free
fatty acid delivery to the liver. Complementarily, IL-1b may
directly limit hepatocyte fat oxidation by inhibiting PPARa [8].
Consistent with these studies, our study shows that IL-1b
deficiency results in reduced liver steatosis and reduced insulin
resistance. However in addition, our findings suggest that IL-1b
may also limit adipose tissue expandability: in its absence a marked
increase in whole-body fat mass was observed. Intriguingly,
adipocytes of IL-1bKO-HFF showed a similar cell-size distribution
to that seen in WT-HFF, implying that the larger fat depot mass is
the result of larger total number of adipocytes (i.e., hyperplasia).
IL-1b was previously shown to inhibit adipogenesis [22,23], and
here we show that whereas in WT mice HFF decreases expression
of genes involved in adipogenesis, the opposite response to HFF is
induced in IL-1bKO mice, revealing an IL-1b-mediated blockade
on adipose tissue expandability.
Limited adipose tissue expandability, particularly in subcutane-
ous fat, has been suggested to exert a causative role in obesity-
associated morbidity (the "ectopic fat/lipid overflow" theory [34]).
According to this view, adipose tissue is the metabolically safe site
for excessive lipid storage, hence when storage capacity is
exhausted, lipid overflows to non-adipose tissues causing ectopic
fat accumulation and in turn, metabolic dysfunction [35].
Hypertrophied adipocyte cell death could trigger adipose inflam-
mation, and pro-inflammatory cytokines (including IL-1b) can
inhibit key adipogenesis genes like pparg. Thus, it is likely that IL-
1b participates in either hypertrophic adipocyte cell death that
launches the inflammatory cascade, and/or directly in limiting
adipose hyperplastic response and expandability. Jointly, these
contribute to ectopic fat accumulation, impaired adipose-liver
crosstalk and obesity-associated morbidity.
IL-1b Regulation of Adipose Tissue Inflammation in
Obesity
What is IL-1b’s role in adipose tissue inflammation in obesity?
In the absence of IL-1b total adipose tissue leukocyte and
macrophage counts were lower under HFF, and obesity-associated
increase in expression of M1 (classically-activated) macrophage
markers seemed less pronounced (ccl2, cxcl10, cxcl13) or completely
absent (ccl8). HFF-induced changes in M2 (alternatively-activated)
macrophage markers were also lower in IL-1bKO mice. This
suggests that a major role of IL-1b in adipose tissue inflammation
is in the recruitment of macrophages to adipose tissue, although a
more subtle regulation of specific macrophage inflammatory
signature markers is plausible. These findings are consistent with
observations in NLRP3-KO mice [5,6]. Although the overall
conclusion (i.e., of a key role for the IL-1b/IL-1R in obesity-
associated adipose tissue inflammation) is well consistent with the
findings in IL-1RIKO mice [9], the inconsistencies are also worth
noting given that both models target the exact biological system. In
IL-1RIKO mice ATMs were functionally less inflammatory, but
their numbers (both total and M1 macrophages defined by being
CD11c+) were not changed compared to WT. The reasons for this
apparent discrepancy are unknown, and could result from
differences in experimental conditions (different diets were used
in both studies), from different compensatory changes induced by
knocking out each of the two genes, and/or represent true
biological differences when targeting the cytokine versus its
receptor. For example, absence of the receptor, even without
inducing compensatory up-regulation of receptors for other pro-
inflammatory cytokines, could induce changes in abundance/
availability of intracellular receptor partners that are common
between IL-1RI and TLR’s signaling. Interestingly, in our study
lack of IL-1RI in primary hepatocyte did not prevent insulin
resistance induce by adipose tissue explants from WT-HFF mice,
whereas the absence of IL-1b in the adipose tissue fragments did
suggest involvement of IL-1b in adipose-hepatocyte crosstalk.
Moreover, in the leptin/leptin receptor mice models, hepatic
steatosis was more severe in ob/ob mice than in db/db mice [36] –
consist with a somewhat milder phenotype when deleting the
receptor versus its ligand. We propose that closer investigation into
these differences may reveal new insights into the specific input of
the "IL-1 system" in obesity.
Our findings also provide in vivo evidence for a role for IL-1b in
promoting triglyceride accumulation in ATMs. Such activity is
reminiscent of in vitro studies using cultured (non adipose-derived)
Figure 5. IL-1b impact on liver and adipose tissue mass and adipose tissue expandability. (A) Representative Computed Tomography (CT)
scans (mid-coronal sections) of WT-NC and WT-HFF mice, and excised epididymal white adipose tissue (eWAT) and livers, and the mean6SEM of their
weights. (B) Similar to A, but for IL-1bKO mice. ***p,0.001 compared to NC. (C) Spearman correlation between epididymal fat pads’ weight and liver
weight in HFF mice. (D) Adipocyte size distribution in WT and IL-1bKO mice, quantified as described in Methods. n = 3–6 mice per group. (E)
Quantitative real-time PCR analysis of the indicated genes in epididymal adipose tissue in WT and IL-1bKO mice, respectively. n = 3–6 per group.
*p,0.05 compared to IL-1bKO-NC ***p,0.0001 compared to WT-NC.
doi:10.1371/journal.pone.0053626.g005
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macrophages [37] and when the effect of IL-1b was tested on
cholesterylester-laden macrophages [38]. Thus, our results suggest
that IL-1b is a regulator of adipose inflammation by promoting
leukocyte and macrophage recruitment, and interestingly, by
enhancing macrophage lipid accumulation.
The Role of IL-1b in Adipose-liver Crosstalk
Using cultured cell lines we have previously proposed an
endocrine role for IL-1b in adipocyte-hepatocyte communication
in response to adipocyte inflammation [25]. Here we estimated the
role of IL-1b in adipose-liver crosstalk by co-culturing fat explants
with primary hepatocytes. Insulin responsiveness was higher in
hepatocytes co-cultured with adipose explants from IL-1bKO-
HFF than WT-HFF mice. A direct role of IL-1b as an endocrine
mediator in adipose-liver crosstalk could be supported by
demonstrating a preferential increase in portal (over systemic)
IL-1b levels in response to HFF. Yet, in the fat explant/primary-
hepatocyte system, antagonizing IL-1b with IL-1Ra only partially,
and with marginal statistical significance, prevented the insulin
resistance observed in liver cells. Furthermore, hepatocytes from
IL-1RIKO mice were not protected against the insulin resistance
induced by co-culturing them with adipose tissue explants from
HFF mice. Thus, only a minor, if any, direct endocrine function of
adipose tissue-derived IL-1b on hepatocytes may be operational.
Rather, it is most likely that IL-1b’s role in regulating the
endocrine function of adipose tissue is mediated by its own
contribution to adipose tissue inflammation via autocrine/para-
crine actions discussed above. The mesenteric transplantation of
adipose tissue from IL-1bKO mice may suggest a unique role for
IL-1b specifically in the adipocytes in this local autocrine-
paracrine function, as host-derived infiltrating cells into the
transplant will have had IL-1b. Indeed, compared to transplan-
tation from a WT donor, mice exhibited a lower pyruvate to
glucose flux. Jointly, it appears that IL-1b may mainly exert
autocrine/paracrine effects in adipose tissue that consequently
deteriorate metabolic adipose-liver crosstalk in obesity.
A Putative Pathway for Adipose IL-1b in the Pathogenesis
of Obesity-associated Morbidity
Our findings along with current literature may suggest the
following patho-physiological pathway: Diet induced obesity
induces adipose tissue inflammation that includes IL-1b up-
regulation, which contributes to the recruitment of adipose tissue
macrophages and to the induction of additional pro-inflammatory
cytokines. These in turn act to limit hyperplastic adipose tissue
expansion, thereby promoting ectopic fat accumulation both
within and outside adipose tissue (ATMs and hepatocytes,
respectively). Ectopic fat accumulation and adipose tissue–derived
inflammatory mediators, then contribute to hepatic steatosis,
hepatic insulin resistance, and augmented pyruvate-glucose flux.
Materials and Methods
Animals and Treatments
The study was approved in advance by Ben-Gurion-University
Institutional Animal Care and Use Committee, and was conduct-
ed according to the Israeli Animal Welfare Act following the
Guide for care and Use of Laboratory Animals (National-Research
Council, 1996). Male wild-type (WT) C57Bl/6 mice were
purchased from Harlan Laboratories (Rehovot, Israel). IL-1b
homozygote knock-out (IL-1bKO) mice on C57Bl/6 background
were generated and used [39,40] as described [41]. Animals were
housed, in the preclinical facility, 2–3 per cage in individually
ventilated cages, which were changed aseptically at least every
week in a class 2A1 biosafety cabinet. Animals were housed in
12:12 light:dark cycle at 20–24uC and 30–70% relative humidity
and had free access to reverse osmosis filtered water. Mice were
allowed free access to autoclaved normal rodent chow (NC, 11%
calories from fat, 65%- carbohydrates and 24%– protein,
Altromin, Lage, Germany). For diet-induced obesity studies, high
fat feeding (HFF) was initiated in parallel in IL-1bKO or WT mice
at age 6–7 weeks using diet consisting of 58.7% calories from fat,
25.5%- carbohydrate, and 15%- protein (Research Diets, New
Brunswick, NJ, D12492) as described in [42]. Due to occasional
sporadic cases of dental abscesses in IL-1bKO mice, all mice (WT
and KO) were given 1.25 ml 5% Enrofloxacin (Bayer Healthcare,
Leverkusen, Germany) in drinking water every second week, with
no effect of antibiotics on weight gain, development of glucose
intolerance or insulin resistance when on HFF. Blood was drawn
from the tail (100 ml) for fasting insulin and glucose measurements.
At the end of the experiment mice were killed with CO2 or
isoflurane, and tissues were obtained and processed as detailed in
following sections. Both C57Bl/6 strains showed a similar weight
gain on HFF compared to mice fed NC (Fig. S4A, B). Yet, while
WT-HFF mice progressively developed impaired insulin tolerance
and insulin resistance (by ITT and HOMA-IR, respectively, (Fig.
S4C–F, Fig. S5A–C)), IL-1bKO-HFF were protected against these
endocrine/metabolic effects of diet-induced obesity.
IL-1b Measurements
The levels were performed in serum by ELISA (Quantikine,
R&D Systems, cat-MLB00C), following the manufacturer’s
instructions with the following adjustments: orbital shaking
(500 rpm, 2 h) during the Assay-Diluent stage and the following
IL-1b conjugate step. This shaking was essential to decrease the
lower detection limit of the kit to 2.35 pg/ml (lowest concentration
in the standard curve, with a coefficient of variance (CV) of
14.9%).
Portally-drained Mesenteric Fat Transplantation
The transplantation was performed at 8 weeks of age on WT
mice as described [17]. Briefly, both epididymal fat pads were
removed from WT or IL-1bKO donor mice, rinsed with 0.9%
saline and stitched to a recipient’s mesenterium using Assu-cryl 6.0
(Assut-Medical, Corgemont, Switzerland). Sham-operated control
mice undergone identical procedures and an artificial suture was
performed. The peritoneum was sealed by Assu-cryl 5.0. Surgical
skin wounds were closed by Reflex skin closure system (Stoelting,
Wood Dale, IL) and 7 mm clips (CellPoint Scientific, Gaithers-
burg, MD). Mice were given 2.5 ml 5%Enrofloxacin and 1.25 g
Dipyrone syrup (Vitamed, Binyamina, Israel) in drinking water for
3 days. After 4 weeks, during which weight gain was identical
between transplanted and sham-operated mice, mice were used for
metabolic assessment as described below.
Primary Mouse Hepatocytes and Co-culture with Adipose
Tissue Explants
Cell isolation was performed as described [43]. Briefly, livers
from WT mice or IL-1RIKO mice (purchased from The Jackson
Laboratory (Bar Harbor, ME)) were perfused via the inferior vena-
cava with Krebs Ringer buffer supplemented with 0.1 mM
EGTA, followed by the same solution with 0.5 mg/ml collagenase
Type1 (Worthington Biochemical Corporation, Lakewood, NJ).
Hepatocytes were collected, centrifuged, washed and plated
(0.256106 cells/well in 6 well collagenI-coated plates) with
DMEM containing 1 g/L glucose and 10% FBS followed by
DMEM/F12 (1:1) media for 24 hours. Cells were co-cultured for
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24 h with ,100 mg epididymal fat fragments from WT or IL-
1bKO mice on HFF after over-night relaxation. IL-1Ra (100 ng/
ml) was added where indicated to the medium. At the end of the
co-culture period explants were removed, and hepatocytes
stimulated with 100 nM insulin for 7 min. Cells were then washed
and lysates prepared for western blot analysis.
FACS Analysis of Adipose Tissue
Epididymal fat pads were excised and minced in 10 ml of
DMEM containing 4.5 mM glucose (without phenol-red), 2 mM
HEPES pH7.4, and 2%BSA. CollagenaseII (Sigma C6885; 1 mg/
ml) was added, and minced tissues were incubated at 37uC for
20 min with shaking. After removing large particles using 250 mm
sieves, 10 mM EDTA was added, followed by 2 centrifugations
(500 g, 5 min, 4uC) to separate floating adipocytes from the
stromal-vascular fraction (SVF) pellets. Following washing, cells
were re-suspended in 300 ml of staining buffer (PBS containing
2%FBS) containing FcBlock (BD-Biosciences, Franklin Lakes, NJ)
and stained with the following conjugated antibodies (all on ice,
10 min in the dark): CD45-APC, F4/80-PE-Cy7 (both from E-
Bioscience, San-Diego, CA) and CD11b-APC-Cy7 (BD-Pharmin-
gen, San-Diego, CA). Thereafter, cells were washed and pellets
were stained for 20 min with Bodipy 493/503 (3 mg/ml Bodipy
for 56106 cells, Invitrogen). Stained samples were further washed
and filtered using 100 mm mesh. Propidium Iodide (0.2 mg/ml,
Sigma) was added to all samples. Stained samples were analyzed
by FACS (Canto, BD-Biosciences, Franklin Lakes, NJ).
RNA Extraction and Quantitative RT-PCR
Total RNA from fat pads was extracted with the RNeasy lipid
tissue mini kit (Qiagen, Germantown, MD) and analyzed with
Nanodrop. RNA (200 ng) was reverse-transcribed with High-
Capacity cDNA Reverse Transcriptase Kit (Applied Biosystems,
Foster City, CA). Taqman system (Applied-Biosystems, Foster
City, CA) was used for real-time PCR amplification. Relative gene
expression was obtained after normalization using the formula 2-
DDCT, using specific primers (Table S1).
Cell Lysates and Western Blot Analysis
Protein lysates (in RIPA buffer) and Western blot analysis were
performed as previously described [25], and bands quantified as
using ImageGauge software (Ver. 4.0, Fuji Photo-Film, Tokyo,
Japan) [44]. In each experiment an insulin-stimulated control
received a value of 1 arbitrary unit, and all samples intensities were
expressed as that value. Antibodies used were: anti-pro-IL-1b
antibody (Abcam, San-Francisco, CA); anti–pSer473-PKB/Akt
antibody, anti–pSer308-PKB/Akt antibody, anti-PKB/Akt anti-
body, anti-pSer9/21-GSK3b antibody, and anti-GSK3b antibody
were from Cell Signaling (Beverly, MA), anti-b-actin and anti-b-
tubulin were from Sigma (St. Louis, MO).
Histology
Haematoxylin-eosin and immunohistological staining were
performed in sections of paraffin-embedded epididymal fat and
livers exactly as described previously [45,46]. The number of
crown like structures (CLS) was determined in 6 different 610
fields from 3–6 mice per group. The percentage of steatosis in liver
histological sections was estimated in 6 different X10 fields from 3–
6 mice from H&E stained sections by two independent observers
blind to the treatment group. All pictures were taken using an
Olympus DP70 microscope. Oil red O staining of liver sections
was performed as described [47].
Fat Cell Size Estimation
The estimation was based on X10 magnification of histological
sections images (SPOT digital camera, Diagnostic Instruments,
Sterling Heights, MI). Images were converted into a binary format
with ImageJ (1.45S Wayne Rasband, NIH, USA) and compared
with the original images to ensure an accurate conversion. Cross-
sectional areas,350 mm2 was considered as technical artifact and
ignored. 50–100 cells/group were measured in 5–7 different X10
fields from 3–6 mice.
Computed Tomography (CT) Scanning
Scans were performed in mice anesthetized with Ketamine and
Xylasine (i.p., 100 and 10 mg/kg body weight, respectively) in
saline. Images were acquired on Philips Mx8000 IDT 16.
Pyruvate Tolerance Tests (PTT)
PTT was performed by i.p injection of 2 g/kg body weight
pyruvate in saline after over night fast, and tail blood measure-
ments every 15 minutes using a glucometer (Abbott, Alameda,
CA).
Statistical Analysis
Data are expressed as the mean6S.E.M. statistically significant
differences between two groups were evaluated using paired or
non-paired Student’s t–test as required (GraphPad software).
Correlation between liver weight and eWAT weight was assessed
using Spearman correlation. p,0.05 was considered statistically
significance.
Supporting Information
Figure S1 Increased adipose tissue expression of IL-1b
in diet induced obesity. (A) Quantitative real-time PCR
analysis of interleukin 1b (IL-1b), interleukin 1a (IL-1a) and
caspase1 (casp1) in epididymal adipose tissue of C57/Bl6 wild-type
(WT) mice during high fat feeding (HFF). Values are adjusted to
18S rRNA, and presented relative to age-matched littermates on
normal chow diet (WT-NC). n= 5–12 per group/time-point; *
p,0.05 compared to WT-NC at the same time point. (B)
Representative western blot and densitometry analysis of pro-IL-
1b in epididymal fat of 16 weeks high fat fed (HFF) or normal
chow (NC) wild-type (WT) mice. A value of one was assigned to
the mean pro-IL-1b to b-tubulin ratio in WT-NC. n= 5 in each
group; *p,0.05.
(PPT)
Figure S2 IL-1b contributes to macrophage lipid accu-
mulation. (A) J774.1 mouse macrophage cell line was incubated
with aggregated LDL or with 0.5 mM oleic acid in the absence or
presence of the indicated IL-1b concentrations. After 18 h cells
were stained with oil red o to stain neutral lipids, and light
microscopy images were taken. (B) Cells from 5 independent
experiments were dissolved with DMSO and absorbance was
determined using a microplate reader assigning an arbitrary value
of 1 to control cells incubated in the absence of either lipids or IL-
1. * p,0.05 compared to control.
(PPT)
Figure S3 High fat diet induced hepatic steatosis is
enhanced by IL-1b. Histological sections of livers of WT-NC,
WT-HFF, IL-1bKO-NC and IL-1bKO-HFF stained for haema-
toxylin and eosin (H&E). WT-HFF and IL-1bKO-HFF were also
stained for the neutral lipid stain Oil red O as detailed in methods.
Shown are representative images of X20 light microscopy fields for
H&E and oil red O.
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(PPT)
Figure S4 IL-1b contributes to the development of
fasting hyperinsulinemia in response to high-fat diet.
(A–B) Body weight dynamics in WT-NC, WT-HFF (n= 8–16)
and in IL-1b knockout mice on normal chow (IL-1bKO-NC) or
high fat diet (IL-1bKO-HFF) (n = 6–13) as a function of weeks of
dietary intervention. WT-HFF were not significantly different
from IL-1bKO-HFF in any of the time points, but differed
significantly (p,0.01) from WT-NC or from IL-1bKO-NC from
week 3 respectively. The same groups were assessed for fasting
insulin (C–D) and homeostasis model assessment insulin resistance
(HOMA-IR)(E–F). * p,0.05 compared to WT-NC.
(PPT)
Figure S5 IL-1b contributes to whole-body insulin
resistance in response to diet induced obesity. (A–B)
Insulin tolerance test (ITT, 0.2 U/Kg body weight after 3 h
fasting) after 12 weeks of HFF or normal chow, and (C) calculated
area under the curve (AUC). * p,0.05 compared to WT-NC.
(PPT)
Table S1 List of Taq-man primers for quantitative real-
time PCR.
(PPT)
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